EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials

An-Wen Chan iD, Isabelle Boutron iD, Sally Hopewell iD, David Moher iD, Kenneth F Schulz iD, Gary S Collins iD, Ruth Tunn iD, Rakesh Aggarwal iD, Michael Berkwits, Jesse A Berlin iD, Nita Bhandari iD, Nancy J Butcher iD und 27 weitere

PLOS Medicine · 28.04.2025 · 22 (4) · e1004589

DOI: 10.1371/journal.pmed.1004589 ↗

Kurz gefasst

Leitlinie in der Zeitschrift PLOS Medicine, online erschienen am 28.04.2025. Verfasst von An-Wen Chan und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council-National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The protocol of a randomised trial is the foundation for study planning, conduct, reporting, and external review. However, trial protocols vary in their completeness and often do not address key elements of design and conduct. The SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) statement was first published in 2013 as guidance to improve the completeness of trial protocols. Periodic updates incorporating the latest evidence and best practices are needed to ensure that the guidance remains relevant to users.

Objective

To systematically update the SPIRIT recommendations for minimum items to address in the protocol of a randomised trial.

Design

We completed a scoping review and developed a project specific database of empirical and theoretical evidence to generate a list of potential changes to the SPIRIT 2013 checklist. The list was enriched with recommendations provided by lead authors of existing SPIRIT/CONSORT (Consolidated Standards of Reporting Trials) extensions (Harms, Outcomes, Non-pharmacological Treatment) and other reporting guidelines (TIDieR). The potential modifications were rated in a three-round Delphi survey followed by a consensus meeting.

Findings

Overall, 317 individuals participated in the Delphi consensus process and 30 experts attended the consensus meeting. The process led to the addition of two new protocol items, revision to five items, deletion/merger of five items, and integration of key items from other relevant reporting guidelines. Notable changes include a new open science section, additional emphasis on the assessment of harms and description of interventions and comparators, and a new item on how patients and the public will be involved in trial design, conduct, and reporting. The updated SPIRIT 2025 statement consists of an evidence-based checklist of 34 minimum items to address in a trial protocol, along with a diagram illustrating the schedule of enrolment, interventions, and assessments for trial participants. To facilitate implementation, we also developed an expanded version of the SPIRIT 2025 checklist and an accompanying explanation and elaboration document. Conclusions and relevance Widespread endorsement and adherence to the updated SPIRIT 2025 statement have the potential to enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, funders, research ethics committees, journals, trial registries, policymakers, regulators, and other reviewers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignHumansChecklistDelphi Technique

Autor:innen und Institutionen

  • Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France.
  • Centre d'Epidémiologie Clinique, Hôpital Hôtel Dieu, AP-HP, Paris, France.
  • Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom.
  • Centre for Journalology, Clinical Epidemiology Programme, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

ORCID-Profile: An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F Schulz, Gary S Collins, Ruth Tunn, Rakesh Aggarwal, Jesse A Berlin, Nita Bhandari, Nancy J Butcher, Marion K Campbell, Diana R Elbourne, Andrew J Farmer, Dean A Fergusson, Robert M Golub, Steven N Goodman, Tammy C Hoffmann, John P A Ioannidis, Rachel L Knowles, Sarah E Lamb, Martin Offringa, Nandi L Siegfried, Sophie Staniszewska, Rod S Taylor, Sunita Vohra, Ian R White, Asbjørn Hróbjartsson

Förderung

  • Medical Research Council-National Institute for Health and Care Research

Zitieren

APA

Chan, A. W., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., Bhandari, N., Butcher, N. J., Campbell, M. K., Chidebe, R. C. W., Elbourne, D. R., Farmer, A. J., Fergusson, D. A., Golub, R. M., Goodman, S. N., …, & Hróbjartsson, A. (2025). SPIRIT 2025 statement: Updated guideline for protocols of randomised trials. PLOS Medicine, 22(4), e1004589. https://doi.org/10.1371/journal.pmed.1004589

Vancouver

Chan AW, Boutron I, Hopewell S, Moher D, Schulz KF, Collins GS, et al. SPIRIT 2025 statement: Updated guideline for protocols of randomised trials. PLOS Medicine. 2025;22(4):e1004589. doi:10.1371/journal.pmed.1004589

BibTeX
@article{Chan2025,
  author = {Chan, An-Wen and Boutron, Isabelle and Hopewell, Sally and Moher, David and Schulz, Kenneth F and Collins, Gary S and Tunn, Ruth and Aggarwal, Rakesh and Berkwits, Michael and Berlin, Jesse A and Bhandari, Nita and Butcher, Nancy J and Campbell, Marion K and Chidebe, Runcie C W and Elbourne, Diana R and Farmer, Andrew J and Fergusson, Dean A and Golub, Robert M and Goodman, Steven N and Hoffmann, Tammy C and Ioannidis, John P A and Kahan, Brennan C and Knowles, Rachel L and Lamb, Sarah E and Lewis, Steff and Loder, Elizabeth and Offringa, Martin and Ravaud, Philippe and Richards, Dawn P and Rockhold, Frank W and Schriger, David L and Siegfried, Nandi L and Staniszewska, Sophie and Taylor, Rod S and Thabane, Lehana and Torgerson, David J and Vohra, Sunita and White, Ian R and Hróbjartsson, Asbjørn},
  title = {SPIRIT 2025 statement: Updated guideline for protocols of randomised trials},
  journal = {PLOS Medicine},
  year = {2025},
  volume = {22},
  number = {4},
  pages = {e1004589},
  doi = {10.1371/journal.pmed.1004589}
}
Kostenlos starten →